Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence
Helgi Thor Hjartarson(Karolinska University Hospital), Thomas Sejersen(Hong Kong Science and Technology Parks Corporation)
Cited by 57